Health Care & Life Sciences » Pharmaceuticals | iCo Therapeutics Inc.

iCo Therapeutics Inc. | Balance Sheet

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,903.40
5,707.80
3,754.00
2,361.00
1,127.90
10.10
Total Accounts Receivable
128.60
39.10
23.80
37.10
88.40
129.80
Other Current Assets
37.00
28.70
25.50
26.20
157.70
35.10
Total Current Assets
2,068.90
5,775.50
3,803.30
2,424.30
1,374.00
175
Net Property, Plant & Equipment
6.40
4.70
5.70
3.50
1.50
3.20
Total Investments and Advances
1,705.20
1,237.20
44.20
2.80
-
-
Intangible Assets
148.50
63.80
42.70
21.50
-
-
Total Assets
3,929.00
7,081.30
3,895.80
2,452.10
1,375.50
178.20
Accounts Payable
273.50
1,507.20
-
-
-
Other Current Liabilities
2,356.90
69.20
115.20
138.20
288.30
Total Current Liabilities
2,630.40
1,576.30
115.20
138.20
288.30
Total Liabilities
2,630.40
1,576.30
115.20
138.20
288.30
Common Equity (Total)
1,298.60
5,504.90
3,780.60
2,313.90
1,087.20
Total Shareholders' Equity
1,298.60
5,504.90
3,780.60
2,313.90
1,087.20
Total Equity
1,298.60
5,504.90
3,780.60
2,313.90
1,087.20
Liabilities & Shareholders' Equity
3,929.00
7,081.30
3,895.80
2,452.10
1,375.50

About iCo Therapeutics

View Profile
Address
777 Hornby Street
Vancouver British Columbia V6Z 2T3
Canada
Employees -
Website http://www.icotherapeutics.com
Updated 07/08/2019
iCo Therapeutics, Inc. engages in the business of identification, development and commercialization of drug candidates for the treatment of sight- and life-threatening diseases. Its products include iCo-008 and oral AmpB delivery system. The company was founded by Andrew J.